cardiovascular disease prevention
Showing 1 - 25 of >10,000
Cardiovascular Diseases, Type 2 Diabetes Trial in Stockholm (Health Dialogue Intervention, Opportunistic Screening)
Not yet recruiting
- Cardiovascular Diseases
- Type 2 Diabetes
- Health Dialogue Intervention
- Opportunistic Screening
-
Stockholm, SwedenCenter for epidemiology and community medicine, Region Stockholm
Sep 27, 2023
Cardiovascular Diseases, Risk Reduction, Primary Prevention Trial (Village doctor-led tailored health management)
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- Village doctor-led tailored health management
- (no location specified)
Dec 7, 2022
Cardiovascular Diseases, Cardiovascular Disease Prevention Trial in Ghent (community pharmacist intervention)
Recruiting
- Cardiovascular Diseases
- Cardiovascular Disease Prevention
- community pharmacist intervention
-
Ghent, BelgiumPharmaceutical Care Unit (Ghent University)
Nov 15, 2023
Cardiovascular Diseases Trial (RASI and/or a single pill combination based RASI)
Not yet recruiting
- Cardiovascular Diseases
- RASI and/or a single pill combination based RASI
- (no location specified)
Sep 29, 2022
HIV/AIDS, Hypertension, Hyperlipidemias Trial in Durham, Cleveland (Multi-component intervention, General prevention education)
Completed
- HIV/AIDS
- +2 more
- Multi-component intervention
- General prevention education
-
Durham, North Carolina
- +2 more
Jan 23, 2023
(DCRI Central and Statistical Coordinating Center)
Completed
- HIV/AIDS
- Cardiovascular Diseases
-
Durham, North Carolina
- +4 more
Aug 19, 2022
Cardiovascular Disease, Hypertension, Care Coordination Trial in United States (Intervention group, Education control group)
Recruiting
- Cardiovascular Disease
- +3 more
- Intervention group
- Education control group
-
Decatur, Georgia
- +3 more
Jul 29, 2022
Cardiovascular Risk Factors Trial in La Forest-Landerneau, Lanmeur (Multi-behavioral intervention)
Completed
- Cardiovascular Risk Factors
- Multi-behavioral intervention
-
La Forest-Landerneau, France
- +1 more
Mar 15, 2022
Cardiovascular Diseases Trial in Ningbo (Frequent and automatic cardiovascular risk assessment, Dynamic risk monitoring, Regular
Not yet recruiting
- Cardiovascular Diseases
- Frequent and automatic cardiovascular risk assessment
- +2 more
-
Ningbo, Zhejiang, ChinaYinzhou District Center for Disease Control and Prevention
Jun 16, 2023
Psoriasis, Psoriatic Arthritis, Psoriatic Conditions Trial (Care Coordinator Model)
Not yet recruiting
- Psoriasis
- +3 more
- Care Coordinator Model
- (no location specified)
Jun 7, 2023
Cardiovascular Disease Trial in Ottawa (PiezoRx medical grade pedometer)
Completed
- Cardiovascular Disease
- PiezoRx medical grade pedometer
-
Ottawa, Ontario, Canada
- +1 more
Feb 8, 2022
Cardiovascular Diseases, Health Behavior Trial (Socio-ecologial, community-based intervention)
Enrolling by invitation
- Cardiovascular Diseases
- Health Behavior
- Socio-ecologial, community-based intervention
- (no location specified)
Nov 24, 2021
Patient-Perceived Versus Trial in Shatin (Cardiovascular prevention guidelines)
Not yet recruiting
- Patient-Perceived Versus
- Cardiovascular prevention guidelines
-
Shatin, Hong KongThe Chinese University of Hong Kong
Jan 12, 2023
Chronic Kidney Disease Trial in Canada (Combined CKD and CVD Prevention, Cardiovascular Disease prevention, Treatment of Chronic
Completed
- Chronic Kidney Disease
- Combined CKD and CVD Prevention
- +3 more
-
Vancouver, British Columbia, Canada
- +4 more
May 9, 2022
Screening and Secondary Prevention Rheumatic Heart Disease Study
Recruiting
- Rheumatic Heart Disease
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases (NICVD)
Aug 12, 2023
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Cardiovascular Prevention, Screening, Peripheral Artery Disease Trial (HELENA)
Not yet recruiting
- Cardiovascular Prevention
- +4 more
- HELENA
- (no location specified)
May 23, 2023
Cardiovascular Risk Factor Trial in Stanford (Plant Sterol)
Completed
- Cardiovascular Risk Factor
- Plant Sterol
-
Stanford, CaliforniaStanford University
Mar 31, 2022
Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- The Cleerly CAD Staging System
- (no location specified)
Oct 31, 2023
Exacerbations and Enhance Rehabilitation - Movement Study
Enrolling by invitation
- Cardiovascular Diseases
- +3 more
- Smartwatch
-
London, United Kingdom (+44), United KingdomImperial College Healthcare NHS Trust
Aug 21, 2023
Cardiovascular Diseases, Dyslipidemias Trial in Yinchuan (Walnuts 30 grams, Walnuts 60 grams)
Completed
- Cardiovascular Diseases
- Dyslipidemias
- Walnuts 30 grams
- Walnuts 60 grams
-
Yinchuan, Ningxia, ChinaYi Zhao
Aug 8, 2022
Zhejiang Nutrition and Healthy Lifespan Study
Not yet recruiting
- Metabolic Disease
- +2 more
-
Hangzhou, Zhejiang, China
- +1 more
Jul 3, 2023
Cardiovascular Primary Prevention Strategy Trial (Coronary Computed Tomography Angiography, Standard Treatment)
Not yet recruiting
- Cardiovascular Primary Prevention Strategy
- Coronary Computed Tomography Angiography
- Standard Treatment
- (no location specified)
Jul 3, 2022
Cohort Study in Fujian Province
Recruiting
- Chronic Disease
-
Fuzhou, Fujian, ChinaFujian Provincial Hospital
Oct 22, 2023
Strategies in Coronary Heart Disease and COVID 19
Not yet recruiting
- Whether the Guidelines on Cardiovascular Disease Prevention Are Being Followed or Not
- Observation
-
Assiut, EgyptAssuit university
Oct 22, 2021